Is ceCT necessary beyond FDG-PET/CT for primary staging in Hodgkin lymphoma?

被引：0

作者：

Kornelia, Kajary ^{[1
]}

Zsuzsa, Molnar ^{[2
]}

Szabolcs, Szakall, Jr. ^{[1
]}

Peter, Molnar ^{[1
]}

Zsolt, Lengyel ^{[1
]}

机构：

[1] Pozitron Diagnoszt Kozpont, Budapest, Hungary

[2] Orszagos Onkologiai Intezet, Budapest, Hungary

来源：

ORVOSI HETILAP | 2014年 / 155卷 / 06期

关键词：

Hodgkin lymphoma; primary staging; 18F-Fluoro-deoxy-glucose; positron emission tomography/computer tomography; contrast-enhanced computer tomography; TOMOGRAPHY; DISEASE; CT;

D O I：

10.1556/OH.2014.29815

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Introduction: Several study supported that 18F-Fluoro-deoxy-glucose (FDG) positron emission tomography/computer tomography with low dose CT (standard PET/CT) is more accurate than contrast-enhanced CT (ceCT) in the primary staging of Hodgkin disease. Aim: The authors compared the accuracy of these examinations with this indication in their practice, and analysed the added value of ceCT which was performed as a supplement to standard PET/CT. Method: Twenty-eight patients were categorized based on ceCT, single standard PET/CT and standard PET/CT with ceCT. Results: Twenty-four patients were in the same disease-stage based on all methods. Disease was upstaged by standard PET/CT compared to ceCT in 4 patients. There was no change in stage when comparing standard PET/CT and standard PET/CT with ceCT. Conclusions: Standard PET/CT is more accurate than ceCT in the primary staging of Hodgkin disease. The authors established that it is not reasonable to supplement standard PET/CT with ceCT in this indication.

引用

页码：226 / 230

页数：5

共 50 条

[1] FDG-PET in the Staging of Patients with Hodgkin's Lymphoma
Castagnoli, A.
Versari, A.
Rigacci, L.
Gallamini, A.
Matteini, M.
Gregianin, M.
Bianchi, A.
Peano, S.
Merli, F.
Vaggelli, L.
Levis, A.
Chisesi, T.
Pelosi, E.
Biggi, A.
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S145 - S145
[2] FDG-PET/CT in Primary Staging of Cholangiocarcinoma
Sabate-Llobera, A.
Gracia-Sanchez, L.
Mestres-Marti, J.
Puig-Povedano, I.
Vercher-Conejero, J. L.
Llinares-Tello, E.
Rodriguez-Bel, L.
Robles-Barba, J. J.
Cortes-Romera, M.
Llado-Garriga, L.
Serrano-Pinol, T.
Ramos-Rubio, E.
Gamez-Cenzano, C.
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S16 - S17
[3] A BONE MARROW BIOPSY IS NOT NECESSARY IN THE STAGING OF HODGKIN LYMPHOMA (HL) PATIENTS IN THE FDG-PET ERA
Richardson, S. E.
Sudak, J.
Warbey, V
Ramsay, A.
McNamara, C.
[J]. HAEMATOLOGICA, 2010, 95 : S39 - S40
[4] Beyond the lymph nodes: FDG-PET/CT in primary extranodal lymphoma
Sin, Kin Man
Ho, Stanton King Dat
Wong, Brian Yung Kong
Gill, Harry
Khong, Pek-Lan
Lee, Elaine Yuen Phin
[J]. CLINICAL IMAGING, 2017, 42 : 25 - 33
[5] Role of FDG-PET in Staging and Therapy of Children with Hodgkin Lymphoma
Kluge, R.
Koerholz, D.
[J]. KLINISCHE PADIATRIE, 2011, 223 (06): : 315 - 319
[6] FDG-PET in Hodgkin lymphoma
Kobe, C.
Dietlein, M.
Mauz-Koerholz, C.
Engert, A.
Borchmann, P.
Sabri, O.
Schober, O.
Schicha, H.
Kluge, R.
[J]. NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2008, 47 (06): : 235 - 238
[7] FDG-PET in staging primary gastrointestinal lymphoma.
Boeck, W
Froehlich, A
Roempp, A
Reske, SN
Lutz, MP
Adler, G
[J]. GASTROENTEROLOGY, 1998, 114 (04) : A566 - A566
[8] FDG-PET in Hodgkin Lymphoma
Hutchings, M.
[J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S16 - S16
[9] Impact of FDG-PET/CT in Staging, Response Evaluation and Decision of Radiotherapy for Pediatric Hodgkin Lymphoma
Khan, Safia
Riaz, Shazia
Ahmecd, Mehoob
Kazmi, Ather
Bashir, Humayun
[J]. BLOOD, 2014, 124 (21)
[10] High SUV uptake on FDG-PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET/CT staging in lymphoma
Ngeow, J. Y. Y.
Quek, R. H. H.
Ng, D. C. E.
Hee, S. W.
Tao, M.
Lim, L. C.
Tan, Y. H.
Lim, S. T.
[J]. ANNALS OF ONCOLOGY, 2009, 20 (09) : 1543 - 1547

← 1 2 3 4 5 →